Stock listing
NASDAQ:CING Cingulate Inc. Stock
Home listing (NASDAQ) of Cingulate Inc.
Follow Cingulate Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CING
$4.98 USD -0.21 (-4.0%)
Close on Oct 30, 2026
- Day range
- $4.84 – $5.10 USDOct 30, 2026
- Volume
- 76,642 sharesOct 30, 2026
- Market cap
- $72.42M USDAt the close on Oct 30, 2026 · price × 14.54M shares outstanding
- 52-week range
- $3.16 – $11.89 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $614,952 USDMedian day 106,150 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CING · Home | $4.98 USD | -0.21 (-4.0%) | 76,642 | $5.04 | $5.10 | $4.84 | $5.19 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:CING · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.98 | -0.21 | -4.0% | $5.04 | $5.10 | $4.84 | 76,642 | |
| $5.19 | -0.06 | -1.1% | $5.18 | $5.24 | $5.09 | 38,814 | |
| $5.25 | -0.28 | -5.1% | $5.38 | $5.405 | $4.93 | 211,792 | |
| $5.53 | +0.35 | +6.8% | $5.351 | $5.676 | $5.206 | 294,706 | |
| $5.18 | +0.20 | +4.0% | $5.00 | $5.27 | $5.00 | 229,557 | |
| $4.98 | +0.32 | +6.9% | $4.64 | $4.98 | $4.605 | 81,092 | |
| $4.66 | 0.00 | 0.0% | $4.60 | $4.822 | $4.60 | 77,950 | |
| $4.66 | +0.13 | +2.9% | $4.53 | $4.70 | $4.50 | 132,403 | |
| $4.53 | +0.17 | +3.9% | $4.37 | $4.635 | $4.24 | 108,412 | |
| $4.36 | 0.00 | 0.0% | $4.35 | $4.48 | $4.26 | 47,818 | |
| $4.36 | -0.03 | -0.7% | $4.39 | $4.44 | $4.12 | 228,600 | |
| $4.39 | -0.18 | -3.9% | $4.55 | $4.575 | $4.28 | 175,800 | |
| $4.57 | -0.15 | -3.2% | $4.66 | $4.77 | $4.562 | 105,300 | |
| $4.72 | -0.12 | -2.5% | $4.85 | $4.94 | $4.675 | 73,200 | |
| $4.84 | -0.05 | -1.0% | $4.81 | $4.889 | $4.81 | 30,200 | |
| $4.89 | +0.01 | +0.2% | $4.87 | $4.975 | $4.77 | 27,800 | |
| $4.88 | +0.01 | +0.2% | $4.84 | $4.98 | $4.75 | 75,700 | |
| $4.87 | -0.02 | -0.4% | $4.82 | $4.96 | $4.67 | 115,600 | |
| $4.89 | +0.14 | +2.9% | $4.75 | $5.00 | $4.75 | 111,400 | |
| $4.75 | -0.01 | -0.2% | $4.82 | $4.905 | $4.63 | 139,800 | |
| $4.76 | +0.01 | +0.2% | $4.79 | $4.904 | $4.705 | 52,100 | |
| $4.75 | -0.20 | -4.0% | $4.95 | $4.95 | $4.735 | 48,800 | |
| $4.95 | +0.045 | +0.9% | $4.91 | $5.02 | $4.82 | 66,300 | |
| $4.905 | +0.085 | +1.8% | $4.88 | $4.97 | $4.837 | 66,600 | |
| $4.82 | -0.01 | -0.2% | $4.97 | $4.97 | $4.59 | 171,900 | |
| $4.83 | -0.23 | -4.5% | $5.01 | $5.12 | $4.80 | 147,500 | |
| $5.06 | +0.08 | +1.6% | $5.015 | $5.07 | $4.81 | 82,500 | |
| $4.98 | -0.165 | -3.2% | $5.10 | $5.22 | $4.93 | 118,200 | |
| $5.145 | -0.085 | -1.6% | $5.26 | $5.35 | $5.125 | 78,100 | |
| $5.23 | -0.01 | -0.2% | $5.27 | $5.48 | $5.21 | 75,500 | |
| $5.24 | +0.09 | +1.7% | $5.11 | $5.28 | $5.09 | 83,200 | |
| $5.15 | +0.06 | +1.2% | $5.17 | $5.19 | $5.00 | 124,400 | |
| $5.09 | -0.02 | -0.4% | $5.16 | $5.21 | $5.09 | 76,700 | |
| $5.11 | -0.06 | -1.2% | $5.16 | $5.21 | $5.03 | 58,900 | |
| $5.17 | +0.15 | +3.0% | $5.00 | $5.19 | $4.80 | 101,200 | |
| $5.02 | -0.15 | -2.9% | $5.22 | $5.28 | $5.02 | 99,600 | |
| $5.17 | -0.04 | -0.8% | $5.17 | $5.41 | $5.155 | 117,500 | |
| $5.21 | +0.02 | +0.4% | $5.24 | $5.40 | $5.16 | 72,500 | |
| $5.19 | +0.09 | +1.8% | $5.09 | $5.28 | $5.05 | 76,400 | |
| $5.10 | -0.12 | -2.3% | $5.21 | $5.498 | $5.02 | 107,000 | |
| $5.22 | +0.07 | +1.4% | $5.19 | $5.27 | $5.06 | 82,000 | |
| $5.15 | +0.04 | +0.8% | $5.14 | $5.25 | $5.11 | 83,300 | |
| $5.11 | -0.06 | -1.2% | $5.16 | $5.215 | $5.03 | 70,500 | |
| $5.17 | -0.155 | -2.9% | $5.33 | $5.33 | $5.02 | 202,100 | |
| $5.325 | -0.115 | -2.1% | $5.48 | $5.49 | $5.256 | 108,400 | |
| $5.44 | +0.04 | +0.7% | $5.50 | $5.60 | $5.37 | 150,600 | |
| $5.40 | -0.47 | -8.0% | $5.86 | $5.86 | $5.36 | 157,800 | |
| $5.87 | +0.19 | +3.3% | $5.71 | $5.94 | $5.65 | 165,700 | |
| $5.68 | +0.13 | +2.3% | $5.51 | $5.93 | $5.335 | 279,800 | |
| $5.55 | +0.22 | +4.1% | $5.35 | $5.55 | $5.18 | 230,800 | |
| $5.33 | +0.06 | +1.1% | $5.21 | $5.38 | $5.037 | 131,600 | |
| $5.27 | +0.07 | +1.3% | $5.15 | $5.30 | $5.01 | 163,300 | |
| $5.20 | -0.01 | -0.2% | $5.17 | $5.28 | $5.10 | 103,500 | |
| $5.21 | +0.12 | +2.4% | $5.11 | $5.315 | $5.08 | 97,600 | |
| $5.09 | +0.10 | +2.0% | $4.92 | $5.13 | $4.711 | 207,600 | |
| $4.99 | -0.22 | -4.2% | $4.96 | $5.08 | $4.80 | 240,300 | |
| $5.21 | +0.01 | +0.2% | $5.15 | $5.23 | $5.02 | 85,300 | |
| $5.20 | -0.05 | -1.0% | $5.28 | $5.35 | $5.14 | 91,300 | |
| $5.25 | -0.09 | -1.7% | $5.26 | $5.349 | $5.142 | 124,700 | |
| $5.34 | +0.29 | +5.7% | $5.10 | $5.36 | $5.03 | 217,400 | |
| $5.05 | +0.11 | +2.2% | $4.95 | $5.10 | $4.92 | 96,400 | |
| $4.94 | +0.04 | +0.8% | $4.96 | $5.10 | $4.91 | 131,900 | |
| $4.90 | +0.07 | +1.4% | $4.84 | $5.10 | $4.81 | 233,800 | |
| $4.83 | +0.04 | +0.8% | $4.87 | $4.95 | $4.685 | 135,200 | |
| $4.79 | +0.03 | +0.6% | $4.81 | $4.84 | $4.635 | 60,600 | |
| $4.76 | +0.235 | +5.2% | $4.53 | $4.85 | $4.47 | 124,700 |
- Ticker
- NASDAQ:CING
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 17, 2026
Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 29 slides
Latest news
Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma
Sep 17, 2026
Closed $5.15 (+1.2%) on Sep 17, 2026
Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness
Aug 13, 2026
Closed $4.99 (-4.2%) on Aug 13, 2026
Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile
Aug 11, 2026
Closed $5.20 (-1.0%) on Aug 11, 2026
Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology
Jul 30, 2026
Closed $4.76 (+5.2%) on Jul 30, 2026
Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®
Jul 2, 2026
Closed $5.38 (-8.7%) on Jul 2, 2026
Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301
Jun 16, 2026
Closed $4.74 (-3.9%) on Jun 16, 2026
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26
Jun 4, 2026
Closed $4.80 (-1.6%) on Jun 4, 2026
Cingulate Receives Complete Response Letter from FDA for CTx-1301
Jun 2, 2026
Closed $4.03 (+11.9%) on Jun 2, 2026
Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301
May 14, 2026
Closed $4.39 (-10.8%) on May 14, 2026
Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Mar 18, 2026
Closed $8.04 (-31.0%) on Mar 18, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 29 slides · October 2026
Investor Presentation (2026)
Investor deck · 26 slides · 2026
Technical Presentation (2025)
Technical · 10 slides · 2025
Investor Presentation (October 2023)
Investor deck · 30 slides · Oct 19, 2023
Cingulate Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 74 in all · newest Sep 17, 2026 · oldest 2021
- Decks
- 11 decks · latest October 2026
Where Cingulate Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CING · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CING | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Cingulate Inc.